Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Although rituximab therapy improves clinical outcome, some patients develop resistant DLBCL; however, the genetic alterations in these patients are not well documented. To identify the genetic background of refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ha Young, Lee, Seung-Bok, Yoo, Hae-Yong, Kim, Seok-Jin, Kim, Won-Seog, Kim, Jong-Il, Ko, Young-Hyeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349924/
https://www.ncbi.nlm.nih.gov/pubmed/27835906
http://dx.doi.org/10.18632/oncotarget.13239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349924/
https://www.ncbi.nlm.nih.gov/pubmed/27835906
http://dx.doi.org/10.18632/oncotarget.13239

Ejemplares similares